Page 201 - Genentech News Today

17.02.2023 - REDWOOD CITY, Calif., Feb. 17, 2023 (GLOBE NEWSWIRE) - Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as chronic ... Seite 1

/PRNewswire/ -- According to Biogens earnings call on Wednesday, February 15, 2023, sales for its multiple sclerosis (MS) franchise are down for the third...

Two Alzheimer's drugs have hit the market in the past year and a half: the first treatment since 2003, and the first looking to target the cause.

People afflicted with autoimmune diseases may someday receive help through treatments now under development by a Lawrence Livermore National Laboratory licensee and its' collaborations with two major pharmaceutical companies.

Richmond, CA (PRWEB) February 15, 2023 -- Education nonprofithttps://mindfullifeproject.org/Mindful Life Project is teaming up with Selena

A court in France has overturned a fine imposed by the French competition authority against the Swiss pharmaceutical companies Novartis and Roche.

A French watchdog said in 2020 Roche and Novartis abused their dominant position to sell a drug used to treat age-related macular degeneration to the detriment of a cheaper treatment.

Brandee Evans is known to many as “Mercedes” on “P-Valley,” but she is also a caregiver for her mom who has MS. Here are some tips she has for...

/PRNewswire/ -- As part of a pre-competitive collaboration with digital health leaders, the Digital Medicine Society (DiMe) launched a suite of new, free...

A report from an Alzheimers Association work group says its time to reframe the meaning of clinically meaningful and change expectations of outcomes from clinical drug trials.